DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr | ₹-139 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
| Mar2021 | ₹-139 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | Positive | |
| Mar2021 | ₹-139 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹22,657.8 Cr | -1.4% | -5% | 8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹105,946.0 Cr | -3.5% | -6.4% | 12.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹90,677.2 Cr | -4.2% | -13.5% | -14.7% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹61,008.2 Cr | -5% | -16.3% | 23.1% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹34,441.9 Cr | -4.8% | -11.4% | 0.3% | Stock Analytics | |
| GLOBAL HEALTH | ₹27,784.9 Cr | -1% | -12.3% | -19% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -1.4% |
-5% |
8% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses